Standard or custom package
excellent quality and reliable supplier
*The following content is generated by AI and is for reference only.
Overview
Voxilaprevir is a direct-acting antiviral (DAA) protease inhibitor developed for treating Hepatitis C. Its molecular formula is C26H30N4O5 and CAS number is 1689837-39-1.
Application
- Combination therapy with sofosbuvir and velpatasvir for chronic HCV infection.
- Used in patients with prior treatment experience or specific genotypes.
- Industrial synthesis focuses on high-purity API production for pharmaceutical formulation.
Precautions
Contraindicated with strong P-gp inducers. Store at controlled room temperature away from moisture. Strict clinical monitoring required for hepatic impairment cases.